To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Why is it different? Disease of the mind affecting understanding and mental ability of the human being - disorder of attention concentration cognition.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
SURROGATE CONSENT LAW: Impact on Research. AB 2328: Surrogate Consent for Research Question: Prior to January 1, 2003, within the state of California,
ETHICS OF CONSENTING IMPAIRED INDIVIDUALS THERAPEUTICS Col Xolani Currie, Nat Dipl Rad, BA, HED, MPH Regulatory Oversight Manager Project Phidisa.
VA Requirements for Vulnerable Subjects Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
GARY HAIGH CAPACITY AND CONSENT. CONSENT Establishing consent is fundamental to respect for patients rights. It is a legal obligation.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Evaluating Risk 1 IRB CELT Presentation Colleen Donaldson – IRB Administrator Julie Wilkens – IRB Coordinator.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Copyright © 2009 AAHRPP ® All rights reserved Accreditation for your Human Research Protection Program David H. Strauss, M.D. NYS Psychiatric Institute,
8 Criteria for IRB Approval of Research 45 CFR (a)
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Idara C.E.. Three ethical principles guides research with human participants. principle of Autonomy 1. The principle of Autonomy requires investigators.
When a Subject Can’t Consent Mary A. Banks Director, BUMC IRB January 17, 2007 No man is good enough to govern another man without that other's consent.
The Goals and Principles of Human Participant Protection Part 4: Vulnerable Populations.
Research with Vulnerable Populations Marisue Cody, PhD, RN IRB Chair Training Washington DC, April 9, 2004.
Recommendations from the Subcommittee on the Inclusion of Individuals With Impaired Decision-making in Research (SIIIDR) March 27, 2008 David H Strauss,
© 2008 Wiggin and Dana Studies Involving Individuals with Impaired Capacity: Assessing Capacity to Consent Michelle Wilcox DeBarge, Esq. Wiggin and Dana.
Help us Help you: IRB Policy Updates Susan Bankowski, MS, JD IRB Chair.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Protection of Vulnerable Subjects in Research Melody Lin, Ph.D. December 2012.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Consent & Vulnerable Adults Aim: To provide an opportunity for Primary Care Staff to explore issues related to consent & vulnerable adults.
APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.
Idara C.E.. Three ethical principles guides research with human participants. principle of Autonomy 1. The principle of Autonomy requires investigators.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Risk Determinations and Research with Children
Enrolling in Clinical Trials
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
HOW TO CONSENT A PATIENT?
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Consent Training Module
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Appendix 2 of New Application
Exploring 45 CFR , Criteria for IRB Approval of Research
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Office of Research Integrity and Protections
Informed Consent Allison Blodgett, PhD, CIP Director of IRB Operations
Presentation transcript:

To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you press enter. Developed by: U-MIC

Cognitively impaired subjects and Legally Authorized Representatives Developed by: U-MIC University of Michigan IRB Collaborative

Cognitive impairment Consent capacity ability to understand information relevant to informed, voluntary decision whether to participate Developed by: U-MIC

Cognitive impairment Cognitive impairment inability/limited ability to provide consent due to impairment of memory understanding reason may be fixed developmental disorders may fluctuate some mental illnesses may worsen over time Alzheimer’s disease may improve some brain injuries affects ability to protect one’s own interests may be compounded by circumstances that limit freedom of choice Developed by: U-MIC

Cognitive impairment Cognitive impairment not limited to psychiatric and neurological diseases may result from stroke trauma drug/alcohol use other causes effect on consent capacity depends on nature of information complexity of information single blood draw versus more complex research Developed by: U-MIC

Cognitively impaired subjects Cognitive impairment Cognitively impaired subjects may face extra vulnerabilities inadequate understanding of their impairments stigma discrimination IRB members/consultants expertise relevant to study design difficulties faced by cognitively impaired individuals judge appropriateness of impaired subjects’ involvement assess subject population’s consent capacity evaluate appropriateness of LAR involvement recommend extra protections tailored to subjects’ impairments Developed by: U-MIC

Cognitively impaired subjects Cognitive impairment Cognitively impaired subjects generally acceptable to involve cognitively impaired subjects in research that meets criteria for IRB approval poses no more than minimal risk includes provisions for LAR’s consent subject’s assent (as appropriate) subject’s affirmative agreement to participate generally not acceptable to involve cognitively impaired subjects in research that poses more than minimal risk unless it offers potential for direct benefit Developed by: U-MIC

evaluating consent capacity Cognitive impairment evaluating consent capacity varies by risk level no more than minimal risk study team’s judgment that subject understands and wishes to participate higher-risk studies formalized evaluation procedures Developed by: U-MIC

Legally authorized representatives (LARs) Cognitive impairment Legally authorized representatives (LARs) authorized under state law to consent on behalf of cognitively impaired subjects should base decision on knowledge of potential subject’s wishes familiarity with potential subject’s beliefs values past decisions potential subject’s interests Developed by: U-MIC

Legally authorized representatives (LARs) Cognitive impairment Legally authorized representatives (LARs) when LAR provides consent Cognitively impaired individual should provide assent (as appropriate). Cognitively impaired individual’s objection should be honored. If subject enrolled with LAR consent gains consent capacity during participation Subject should be asked to consent to continued participation. Developed by: U-MIC

Legally authorized representatives (LARs) Cognitive impairment Legally authorized representatives (LARs) laws vary from state to state consult legal counsel state agency UM IRBs work with Office of the Vice President and Legal Counsel. Developed by: U-MIC

Cognitive impairment IRB may require study team member obtaining consent to sign document indicating that they believe the subject and/or LAR understood study information Developed by: U-MIC

Researchers enrolling cognitively impaired subjects Cognitive impairment Researchers enrolling cognitively impaired subjects consider additional components study team well-experienced with population study information tailored to subjects’ needs monitoring consent/assent capacity and willingness to participate involvement of family member or friend clinician to monitor subjects’ physical and mental well-being LAR during the consent process throughout study Developed by: U-MIC

Cognitively impaired subjects Cognitive impairment Cognitively impaired subjects and legally authorized representatives (LARs) Developed by: U-MIC

Thank you. Adam Mrdjenovich IRB-HSBS Judith Birk IRBMED Developed by: U-MIC